"If you just ask them to solve biology or chemistry questions, they're not particularly good at it. They're trained on the human language, not on the language of chemistry, physics, and biology. This statement from Eli Lilly CEO David Ricks highlights fundamental limitations in current AI systems despite their general capabilities and the substantial investment flowing into AI development."
"Harvard's Sybil AI model in 2023, for example, accurately predicted lung cancer risk within six years. And Google DeepMind's AlphaProteo model has proved instrumental in designing protein binders that target certain molecules, including those associated with cancer. These examples demonstrate concrete advances in AI-assisted cancer research despite broader skepticism about near-term breakthroughs."
"One reason AI investment has reached record levels, rivaling the GDPs of some developed countries, is the belief that the technology could enable revolutionary scientific breakthroughs. During a press briefing announcing President Donald Trump's Project Stargate last year, a $500 billion investment in AI infrastructure through 2029, Oracle CEO Larry Ellison said the project could lead to a cancer vaccine."
Cancer research spans millennia, from ancient Egyptian documentation to modern AI applications. Tech leaders including Google and Anthropic executives predict AI will revolutionize cancer treatment, with some claiming vaccines could be developed within 48 hours. However, medical professionals like Eli Lilly CEO David Ricks express skepticism, noting AI models trained on human language perform poorly on chemistry and biology questions. Despite these concerns, significant progress exists: Harvard's Sybil model accurately predicts lung cancer risk within six years, and Google DeepMind's AlphaProteo successfully designs protein binders targeting cancer-associated molecules. This gap between optimistic predictions and current capabilities reflects ongoing debate about AI's realistic timeline for medical breakthroughs.
#ai-and-cancer-research #medical-breakthroughs #ai-limitations-in-science #technology-investment #healthcare-innovation
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]